Current Biology Review Time

The official ScienceDirect page is unusually helpful because it now publishes stage timings directly. That gives Current Biology a clearer timing profile than many broad-biology journals.

What those numbers do not tell you is how much of the speed comes from editorial confidence about fit. Current Biology is broad, but it is not permissive. Editors are asking whether the paper has a sufficient claim to general interest across biology, not merely whether the experiments are solid.

The better planning model is:

• expect a very fast decision if the manuscript reads as too specialist
• expect a more conventional month-scale process if the paper survives the first screen
• expect the real calendar burden to come from revision and positioning work, not from the first email alone

That is why the 140-day submission-to-acceptance number is often the most useful single planning metric on this page.

Current Biology's own editorial culture reinforces that split. Cell Press has published a dedicated note on how Current Biology presubmissions help authors and editors align on fit early, which helps explain why the front-end timing can be so compressed compared with the later acceptance path.

The most important point is that Current Biology is not a uniformly fast journal. It is a journal with a very fast editorial front end and a meaningfully longer full acceptance path.

Current Biology is one of the clearest examples of a journal where editorial identity drives speed. The journal is broad by subject area, but narrow in taste. Editors can reject quickly when they conclude the paper is:

• too specialist in real audience even if the science is good
• more suitable for a narrower Cell Press or field journal
• conceptually interesting only inside one subfield
• still one narrative step short of cross-field readability
• written in a way that assumes specialist commitment too early

That is why the journal's 3-day first-decision number should be read as a sign of strong editorial confidence, not as proof that every reviewed paper moves at that speed.

The slower files are usually not obviously wrong for the journal. They are the ones that force a harder editorial argument.

The common causes are:

• reviewer disagreement about whether the finding is genuinely broad-interest
• a story that is elegant scientifically but still specialist in framing
• cross-field reviewer routing, especially when the paper spans methods or organisms awkwardly
• requests to tighten the claim so the paper reads less like a field paper and more like a Current Biology paper
• revision rounds where the experiments are good but the editorial story still needs work

When Current Biology feels slow, it is often because the journal is testing communicative breadth as much as experimental strength.

Current Biology is down from 10.8 in 2023 to 7.5 in 2024, which should be read more as citation normalization than editorial collapse. The journal is still broad, still selective about interest, and still able to reject quickly when the fit is wrong.

For review time, that matters because Current Biology does not need to behave like a volume journal. It can keep using the first screen aggressively, which is why the front-end timing remains so sharp.

Even this relatively transparent journal still hides a few things:

• the first-decision number is strongly compressed by desk rejects
• the decision-after-review number does not capture the emotional cost of revision
• broad-interest debate is often the real determinant of pace
• timing alone will not tell you whether the paper is too specialist for the venue

So the numbers are useful, but the editorial identity matters more than the clock.

In our pre-submission review work, the biggest timing mistake is assuming that good biology plus Cell Press branding is enough. Current Biology usually moves fastest when the editorial argument is already obvious.

The manuscripts that tend to move best have:

• a title and abstract that explain the finding beyond one niche
• a narrative center that survives contact with non-specialists
• a clean reason the paper belongs in Current Biology rather than a narrower title
• figures that make the biological consequence visible early

Those traits make the fast desk screen help the paper instead of hurt it.

For Current Biology, timing matters less than cross-field legibility. The better question is whether the manuscript already behaves like a Current Biology paper.

That is why the better next reads are:

• Current Biology journal profile
• Current Biology submission guide
• Current Biology submission process
• Current Biology impact factor

A Current Biology broad-interest check is usually more useful than trying to optimize around the desk clock alone.

Current Biology review time is best understood as a split story: very fast editorial triage, then a more normal acceptance path for papers that survive. The journal really does move quickly, but the main thing that moves quickly is its judgment about fit. If the story is broad enough, the process can be efficient. If not, the answer usually comes fast.